Tool for non-invasive delivery of central nervous system drug candidates
Ended Cooperative Agreement Awarded Last action
- Award ID
- R44MH099720
- Recipient
-
Impel Pharmaceuticals Inc. UEI VGX8L65CX5A3
- Awarding agency
-
National Institute of Mental Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,165,186
Award facts
- Assistance listing
- 93.242 Mental Health Research Grants
- Completion date
- Originally
- Place of performance
- Seattle, WA 98122, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$323,523 | |
| Amendment | $0 | |
| Amendment | $574,487 | |
| Original award | $914,222 |
Quick answers
Who received award R44MH099720?
R44MH099720 was awarded to Impel Pharmaceuticals Inc. by National Institute of Mental Health (National Institutes of Health) on November 20, 2012.
How much is award R44MH099720 worth?
$1,165,186 has been obligated on R44MH099720.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award